Luca Boscolo Bielo

ORCID

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 14

Top Venues

The oncologist

Expert opinion on drug metabolism & toxicology

This page only lists publications with an associated author ORCID identifier.

Publications

Luca Boscolo Bielo, Matteo Repetto, Edoardo Crimini, Carmen Belli, Elisabetta Setola, Gabriella Parma, Nicola Fusco, Massimo Barberis, Elena Guerini Rocco, Antonio Marra, Nicoletta Colombo, Curigliano Giuseppe
Clinical actionability of BRCA2 alterations in uterine leiomyosarcoma: a molecular tumor board case report and a cBioPortal comprehensive analysis. The oncologist 29 (7) (2024)
Carmen Belli, Luca Boscolo Bielo, Matteo Repetto, Edoardo Crimini, Raimondo Scalia, Anna Diana, Jessica Orefice, Liliana Ascione, Gloria Pellizzari, Nicola Fusco, Massimo Barberis, Bruno Daniele, Elena Guerini-Rocco, Curigliano Giuseppe
Deleterious alterations in homologous recombination repair genes and efficacy of platinum-based chemotherapy in biliary tract cancers. The oncologist 29 (8) (2024)
Luca Boscolo Bielo, Carmen Belli, Edoardo Crimini, Matteo Repetto, Liliana Ascione, Gloria Pellizzari, Celeste Santoro, Valeria Fuorivia, Massimo Barberis, Nicola Fusco, Elena Guerini Rocco, Curigliano Giuseppe
Cancers of Unknown Primary Origin: Real-World Clinical Outcomes and Genomic Analysis at the European Institute of Oncology. The oncologist 29 (6) (2024)
Luca Boscolo Bielo, Matteo Repetto, Edoardo Crimini, Carmen Belli, Elisabetta Setola, Gabriella Parma, Nicola Fusco, Massimo Barberis, Elena Guerini Rocco, Antonio Marra, Nicoletta Colombo, Curigliano Giuseppe
Clinical actionability of BRCA2 alterations in uterine leiomyosarcoma: a molecular tumor board case report and a cBioPortal comprehensive analysis. The oncologist 29 (7) (2024)
Luca Boscolo Bielo, Matteo Repetto, Edoardo Crimini, Carmen Belli, Elisabetta Setola, Gabriella Parma, Nicola Fusco, Massimo Barberis, Elena Guerini Rocco, Antonio Marra, Nicoletta Colombo, Curigliano Giuseppe
Clinical actionability of BRCA2 alterations in uterine leiomyosarcoma: a molecular tumor board case report and a cBioPortal comprehensive analysis. The oncologist 29 (7) (2024)
Luca Boscolo Bielo, Carmen Belli, Edoardo Crimini, Matteo Repetto, Liliana Ascione, Gloria Pellizzari, Celeste Santoro, Valeria Fuorivia, Massimo Barberis, Nicola Fusco, Elena Guerini Rocco, Curigliano Giuseppe
Cancers of Unknown Primary Origin: Real-World Clinical Outcomes and Genomic Analysis at the European Institute of Oncology. The oncologist 29 (6) (2024)
Luca Boscolo Bielo, Matteo Repetto, Edoardo Crimini, Carmen Belli, Elisabetta Setola, Gabriella Parma, Nicola Fusco, Massimo Barberis, Elena Guerini Rocco, Antonio Marra, Nicoletta Colombo, Curigliano Giuseppe
Clinical actionability of BRCA2 alterations in uterine leiomyosarcoma: a molecular tumor board case report and a cBioPortal comprehensive analysis. The oncologist 29 (7) (2024)
Luca Boscolo Bielo, Carmen Belli, Edoardo Crimini, Matteo Repetto, Liliana Ascione, Gloria Pellizzari, Celeste Santoro, Valeria Fuorivia, Massimo Barberis, Nicola Fusco, Elena Guerini Rocco, Curigliano Giuseppe
Cancers of Unknown Primary Origin: Real-World Clinical Outcomes and Genomic Analysis at the European Institute of Oncology. The oncologist 29 (6) (2024)
Luca Boscolo Bielo, Carmen Belli, Edoardo Crimini, Matteo Repetto, Liliana Ascione, Gloria Pellizzari, Celeste Santoro, Valeria Fuorivia, Massimo Barberis, Nicola Fusco, Elena Guerini Rocco, Curigliano Giuseppe
Cancers of Unknown Primary Origin: Real-World Clinical Outcomes and Genomic Analysis at the European Institute of Oncology. The oncologist 29 (6) (2024)
Luca Boscolo Bielo, Matteo Repetto, Edoardo Crimini, Carmen Belli, Elisabetta Setola, Gabriella Parma, Nicola Fusco, Massimo Barberis, Elena Guerini Rocco, Antonio Marra, Nicoletta Colombo, Curigliano Giuseppe
Clinical actionability of BRCA2 alterations in uterine leiomyosarcoma: a molecular tumor board case report and a cBioPortal comprehensive analysis. The oncologist (2024)
Luca Boscolo Bielo, Carmen Belli, Edoardo Crimini, Matteo Repetto, Liliana Ascione, Gloria Pellizzari, Celeste Santoro, Valeria Fuorivia, Massimo Barberis, Nicola Fusco, Elena Guerini Rocco, Curigliano Giuseppe
Cancers of Unknown Primary Origin: Real-World Clinical Outcomes and Genomic Analysis at the European Institute of Oncology. The oncologist (2024)
Carmen Belli, Luca Boscolo Bielo, Matteo Repetto, Edoardo Crimini, Raimondo Scalia, Anna Diana, Jessica Orefice, Liliana Ascione, Gloria Pellizzari, Nicola Fusco, Massimo Barberis, Bruno Daniele, Elena Guerini-Rocco, Curigliano Giuseppe
Deleterious alterations in homologous recombination repair genes and efficacy of platinum-based chemotherapy in biliary tract cancers. The oncologist 29 (8) (2024)
Carmen Belli, Luca Boscolo Bielo, Matteo Repetto, Edoardo Crimini, Raimondo Scalia, Anna Diana, Jessica Orefice, Liliana Ascione, Gloria Pellizzari, Nicola Fusco, Massimo Barberis, Bruno Daniele, Elena Guerini-Rocco, Curigliano Giuseppe
Deleterious alterations in homologous recombination repair genes and efficacy of platinum-based chemotherapy in biliary tract cancers. The oncologist (2024)
Luca Boscolo Bielo, Stefano Natangelo, Jalissa Katrini, Dario Trapani, Curigliano Giuseppe
A comprehensive update of hormone-related pharmacokinetic variations associated with breast cancer drugs. Expert opinion on drug metabolism & toxicology (2023)

Luca Boscolo Bielo.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Luca Boscolo Bielo